Intraoperative Methadone in Children Undergoing Surgery
NCT ID: NCT04680286
Last Updated: 2024-02-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
PHASE3
60 participants
INTERVENTIONAL
2020-11-16
2024-02-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Methadone vs. Fentanyl Administration on Postoperative Pain Control in Pediatric Patients Undergoing Cardiac Surgery
NCT02747875
Methadone in Cystectomy Patients
NCT04475029
Optimizing Perioperative Analgesia to Lower Pain Following Cleft Palate Surgery
NCT06962306
Clinical Effectiveness and Safety of Intraoperative Methadone in Patients Undergoing Laparoscopic Hysterectomy
NCT03908060
Opioid Versus Non-opioid Anesthesia for Ambulatory Surgery in Children
NCT03979469
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In children, methadone has shown a half-life of 19,2 +/-13,6 hours. Regarding outpatient surgery, methadone is an opioid with unique pharmalogical properties that may be advantageous. A single-dose of this long acting opioid administered perioperatively could provide a stable analgesia and potentially reduce the need for shorter-acting opioids in the PACU and at home.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Placebo
A 5 ml syringe with saline will be prepared and study drug will be administered as intravenous bolus dose (0.1 mg/kg). The study drug will be administered at induction of anesthesia.
Placebo
Single dose, intravenous bolus. Administered as the experimental arm.
Methadone
A 5 ml syringe with 1 mg/ml of methadone will be prepared and study drug will be administered as intravenous bolus dose (0.1 mg/kg). The study drug will be administered at induction of anesthesia.
Methadone Hydrochloride
Single dose, intravenous bolus, 0,1 mg/kg administered at induction of anesthesia.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Methadone Hydrochloride
Single dose, intravenous bolus, 0,1 mg/kg administered at induction of anesthesia.
Placebo
Single dose, intravenous bolus. Administered as the experimental arm.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Born preterm (Before gestational age of 37 weeks)
* Congenital heart disease
* Previous scrotal surgery
* Laparoscopic operation
* American Society of Anaesthesiologists (ASA) physical status lll, IV or V
* Allergy to study drugs
* Preoperative daily use of opioids
* Parents with inability to provide informed consent
* Severe respiratory insufficiency
* Acute abdominal pain
* Severe kidney insufficiency
* Treatment with rifampicin
0 Years
4 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Aarhus
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Aarhus University Hospital
Aarhus, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020-002945-41
Identifier Type: EUDRACT_NUMBER
Identifier Source: secondary_id
23956082
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.